CollPlant Biotechnologies

$14.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.21 (+9.11%) As of 4:36 PM UTC today

Why Robinhood?

You can buy or sell CLGN and other stocks, options, and ETFs commission-free!

About CLGN

CollPlant Biotechnologies Ltd American Depositary Shares, also called CollPlant Biotechnologies, is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel. The listed name for CLGN is CollPlant Biotechnologies Ltd American Depositary Shares.

CEO
Yehiel Tal
Employees
46
Headquarters
Rehovot, Tel Aviv
Founded
2004
Market Cap
95.97M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
483.77K
High Today
$14.64
Low Today
$13.50
Open Price
$13.85
Volume
97.16K
52 Week High
$24.26
52 Week Low
$6.00

CLGN Earnings

-$0.41
-$0.24
-$0.06
$0.11
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 31, Pre-Market

You May Also Like

ICCH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure